Mark Coleman, Director at Axsome Therapeutics, Inc. (AXSM), sold 59,176 shares at $75.18 ($4.4M) on 2023-09-15, disclosed to the SEC on 2023-09-15.
Scheduled sale ($4.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.18 | 18,572 | $1.4M | 31.4% |
| 2 | $75.18 | 18,572 | $1.4M | 31.4% |
| 3 | $75.19 | 11,016 | $828K | 18.6% |
| 4 | $75.19 | 11,016 | $828K | 18.6% |
| Total | $75.18 avg | 59,176 | $4.4M | 100% |
| Filing → |
| AXSM | SELL | 2026-02-27 | $4.0M | — | Filing → |
| AXSM | BUY | 2025-09-09 | $263K | — | Filing → |
| AXSM | SELL | 2025-05-29 | $1.6M | — | Filing → |